Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Boguslawa Korona

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
The Journal of Biological Chemistry|October 25, 2024
How to target membrane proteins for degradation: Bringing GPCRs into the TPD foldBoguslawa Korona, Laura S Itzhaki
Blood|June 4, 2021
GPR34 activation potentially bridges lymphoepithelial lesions to genesis of salivary gland MALT lymphomaBoguslawa Korona, Dagmara Korona, Wanfeng Zhao, et al.
Plos Biology|October 13, 2020
Correction: A kinase-dependent checkpoint prevents escape of immature ribosomes into the translating poolMelissa D Parker, Jason C Collins, Boguslawa Korona, et al.
Haematologica|February 10, 2022
CCR6 activation links innate immune responses to mucosa-associated lymphoid tissue lymphoma developmentBoguslawa Korona, Dagmara Korona, Wanfeng Zhao, et al.
Advances in Experimental Medicine and Biology|July 22, 2018
Structural Insights into Notch Receptor-Ligand InteractionsPenny A Handford, Boguslawa Korona, Richard Suckling, et al.
Plos Biology|December 14, 2019
A kinase-dependent checkpoint prevents escape of immature ribosomes into the translating poolMelissa D Parker, Jason C Collins, Boguslawa Korona, et al.
The EMBO Journal|June 3, 2017
Structural and functional dissection of the interplay between lipid and Notch binding by human Notch ligandsRichard J Suckling, Boguslawa Korona, Pat Whiteman, et al.
EMBO Reports|August 4, 2021
The conserved C2 phospholipid-binding domain in Delta contributes to robust Notch signallingTorcato Martins, Yao Meng, Boguslawa Korona, et al.
Genome Research|September 8, 2012
Natural genetic variation in yeast longevityStefan W Stumpferl, Sue E Brand, James C Jiang, et al.
RSC Chemical Biology|June 15, 2026
<i>De novo</i> grafted coiled-coil peptides as p53/<i>h</i>DM2 inhibitorsFreya Spain, Diana Gimenez, Amanda M Acevedo-Jake, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
The Journal of Biological Chemistry|October 25, 2024
How to target membrane proteins for degradation: Bringing GPCRs into the TPD foldBoguslawa Korona, Laura S Itzhaki
Blood|June 4, 2021
GPR34 activation potentially bridges lymphoepithelial lesions to genesis of salivary gland MALT lymphomaBoguslawa Korona, Dagmara Korona, Wanfeng Zhao, et al.
Plos Biology|October 13, 2020
Correction: A kinase-dependent checkpoint prevents escape of immature ribosomes into the translating poolMelissa D Parker, Jason C Collins, Boguslawa Korona, et al.
Haematologica|February 10, 2022
CCR6 activation links innate immune responses to mucosa-associated lymphoid tissue lymphoma developmentBoguslawa Korona, Dagmara Korona, Wanfeng Zhao, et al.
Advances in Experimental Medicine and Biology|July 22, 2018
Structural Insights into Notch Receptor-Ligand InteractionsPenny A Handford, Boguslawa Korona, Richard Suckling, et al.
Plos Biology|December 14, 2019
A kinase-dependent checkpoint prevents escape of immature ribosomes into the translating poolMelissa D Parker, Jason C Collins, Boguslawa Korona, et al.
The EMBO Journal|June 3, 2017
Structural and functional dissection of the interplay between lipid and Notch binding by human Notch ligandsRichard J Suckling, Boguslawa Korona, Pat Whiteman, et al.
EMBO Reports|August 4, 2021
The conserved C2 phospholipid-binding domain in Delta contributes to robust Notch signallingTorcato Martins, Yao Meng, Boguslawa Korona, et al.
Genome Research|September 8, 2012
Natural genetic variation in yeast longevityStefan W Stumpferl, Sue E Brand, James C Jiang, et al.
RSC Chemical Biology|June 15, 2026
<i>De novo</i> grafted coiled-coil peptides as p53/<i>h</i>DM2 inhibitorsFreya Spain, Diana Gimenez, Amanda M Acevedo-Jake, et al.
Pageof 2